Publication
, Other
Dodd, RD; Scherer, A; Huang, W; McGivney, GR; Gutierrez, WR; Laverty, EA; Ashcraft, KA; Stephens, VR; Yousefpour, P; Saha, S; Knepper-Adrian, V ...
March 31, 2023
APA
Chicago
ICMJE
MLA
NLM
Dodd, R. D., Scherer, A., Huang, W., McGivney, G. R., Gutierrez, W. R., Laverty, E. A., … Kirsch, D. G. (2023). Data from Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in <i>Pten</i>-deleted Mouse Models of Sarcoma. https://doi.org/10.1158/1078-0432.c.6529004.v1
Dodd, Rebecca D., Amanda Scherer, Wesley Huang, Gavin R. McGivney, Wade R. Gutierrez, Emily A. Laverty, Kathleen A. Ashcraft, et al. “Data from Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in <i>Pten</i>-deleted Mouse Models of Sarcoma,” March 31, 2023. https://doi.org/10.1158/1078-0432.c.6529004.v1.
Dodd RD, Scherer A, Huang W, McGivney GR, Gutierrez WR, Laverty EA, et al. Data from Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in <i>Pten</i>-deleted Mouse Models of Sarcoma. 2023.
Dodd, Rebecca D., et al. Data from Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in <i>Pten</i>-deleted Mouse Models of Sarcoma. 31 Mar. 2023. Crossref, doi:10.1158/1078-0432.c.6529004.v1.
Dodd RD, Scherer A, Huang W, McGivney GR, Gutierrez WR, Laverty EA, Ashcraft KA, Stephens VR, Yousefpour P, Saha S, Knepper-Adrian V, Floyd W, Chen M, Ma Y, Mastria EM, Cardona DM, Eward WC, Chilkoti A, Kirsch DG. Data from Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in <i>Pten</i>-deleted Mouse Models of Sarcoma. 2023.